These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 37675821)
1. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review. Nahar Metu CL; Sutihar SK; Sohel M; Zohora F; Hasan A; Miah MT; Rani Kar T; Hossain MA; Rahman MH Cancer Rep (Hoboken); 2023 Oct; 6(10):e1889. PubMed ID: 37675821 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations. Murakami C; Yoshida Y; Yamazaki T; Yamazaki A; Nakata S; Hokama Y; Ishiuchi S; Akimoto J; Shishido-Hara Y; Yoshimoto Y; Matsumura N; Nobusawa S; Ikota H; Yokoo H Brain Tumor Pathol; 2019 Jul; 36(3):103-111. PubMed ID: 30972500 [TBL] [Abstract][Full Text] [Related]
4. A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma. Kuroda J; Nobusawa S; Nakamura H; Yokoo H; Ueda R; Makino K; Yano S; Kuratsu J Neuropathology; 2016 Apr; 36(2):181-6. PubMed ID: 26375727 [TBL] [Abstract][Full Text] [Related]
5. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma. Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415 [TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAF V600E mutation. Kanamori M; Suzuki H; Takei H; Sonoda Y; Uenohara H; Tominaga T Brain Tumor Pathol; 2016 Jan; 33(1):50-6. PubMed ID: 26404554 [TBL] [Abstract][Full Text] [Related]
7. A case of high-grade astrocytoma with BRAF and ATRX mutations following a long-standing course over two decades. Nakata S; Horiguchi K; Ishiuchi S; Yoshimoto Y; Yamada S; Nobusawa S; Ikota H; Hirato J; Yokoo H Neuropathology; 2017 Aug; 37(4):351-357. PubMed ID: 28185325 [TBL] [Abstract][Full Text] [Related]
8. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770 [TBL] [Abstract][Full Text] [Related]
9. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552 [TBL] [Abstract][Full Text] [Related]
15. MAPK pathway activation and the origins of pediatric low-grade astrocytomas. Tatevossian RG; Lawson AR; Forshew T; Hindley GF; Ellison DW; Sheer D J Cell Physiol; 2010 Mar; 222(3):509-14. PubMed ID: 19937730 [TBL] [Abstract][Full Text] [Related]
16. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features. Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. Eisenhardt AE; Olbrich H; Röring M; Janzarik W; Anh TN; Cin H; Remke M; Witt H; Korshunov A; Pfister SM; Omran H; Brummer T Int J Cancer; 2011 Nov; 129(9):2297-303. PubMed ID: 21190184 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530 [TBL] [Abstract][Full Text] [Related]
19. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis. Hong B; Banan R; Christians A; Nakamura M; Lalk M; Lehmann U; Hartmann C; Krauss JK Acta Neurochir (Wien); 2018 Nov; 160(11):2237-2248. PubMed ID: 30203362 [TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of BRAF status in glial and glioneuronal tumors: A systematic review. Sugiura Y; Nagaishi M J Clin Neurosci; 2019 Aug; 66():196-201. PubMed ID: 31147232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]